Trillium Therapeutics Inc (TRIL)

[NY1972]

Patients with colorectal cancer who search for open trials on the site are offered more than 1,400 different options. The search terms “colorectal cancer” and “immunotherapy” yield 79 open trials.

Checkpoint inhibitors have been shown to work dramatically — that is, for some of the 20 percent to 40 percent of patients who actually respond to the drugs. So far, that list mostly includes patients with cancers of the bladder, kidney, lung, and skin and Hodgkin’s lymphoma, and a tiny fraction of colon cancer patients: those with so-called microsatellite-instable, or “MSI high,” tumors.

https://www.statnews.com/2016/10/06/immunotherapy-cancer-clinical-trials/?s_campaign=stat:rss